Invasive zygomycosis in transplant recipients

Clinical Transplantation

Volumn 21, Issue 4, 2007, Pages 577-582

  Uçkay, Ilker ^a   Chalandon, Yves ^a   Sartoretti, Pascal ^a   Rohner, Peter ^a   Berney, Thierry ^a   Hadaya, Karine ^a   van Delden, Christian ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Rhizomucor; Rhizopus; Transplantation; Zygomycosis

Indexed keywords

ALEMTUZUMAB; AMIKACIN; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CEFEPIME; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEFEROXAMINE; FLUCONAZOLE; GANCICLOVIR; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TEICOPLANIN; THYMOCYTE ANTIBODY; VANCOMYCIN;

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; BRAIN INFECTION; CASE REPORT; CATHETER INFECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FATALITY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART DISEASE; HEMOCHROMATOSIS; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG INFECTION; MALE; MUCORMYCOSIS; NEUROTOXICITY; PRIORITY JOURNAL; RHIZOMUCOR; SKIN INFECTION; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BONE MARROW TRANSPLANTATION; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUCORMYCOSIS; OPPORTUNISTIC INFECTIONS; POSTOPERATIVE COMPLICATIONS; RHIZOPUS; ZYGOMYCOSIS;

EID: 34547489605     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00684.x     Document Type: Article

References (20)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000: 13: 236.
2. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005: 41: 634.
3. Almyroudis NG, Sutton DA, Linden P et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006: 6: 2365.
4. Yeung CK, Cheng VC, Lie AK et al. Invasive disease due to Mucorales: A case report and review of the literature. Hong Kong Med J 2001: 7: 180.
5. Maertens J, Demuynck H, Verbeken EK et al. Mucormycosis in allogeneic bone marrow transplant recipients: Report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999: 24: 307.
6. Morrison VA, Mcglave PB. Mucormycosis in the BMT population. Bone Marrow Transplant 1993: 11: 383.
7. Davari HR, Malekhossini SA, Salahi HA et al. Outcome of mucormycosis in liver transplantation: Four cases and a review of literature. Exp Clin Transplant 2003: 1: 147.
8. Venkattaramanabalaji GV, Foster D, Greene JN et al. Mucormycosis associated with deferoxamine therapy after allogeneic bone marrow transplantation. Cancer Control 1997: 4: 168.
9. de Locht M, Boelaert JR, Schneider YJ. Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol 1994: 47: 1843.
10. K ontoyiannis DP, L ionakis MS, L ewis RE et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus - active antifungal therapy: A case-control observational study of 27 recent cases. J Infect Dis 2005: 191: 1350.
11. Singh N, Gayowski T, Singh J et al. Invasive gastrointestinal zygomycosis in a liver transplant recipient: Case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995: 20: 617.
12. Jimenez C, Lumbreras C, Aguado JM et al. Successful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation 2002: 73: 476.
13. Severo LC, Oliveira FD, Dreher R et al. Zygomycosis: A report of eleven cases and a review of the brazilian literature. Rev Iberoam Micol 2002: 19: 52.
14. Cook BA, White CB, Blaney SM et al. Survival after isolated cerebral mucormycosis. Am J Pediatr Hematol Oncol 1989: 11: 330.
15. Vera A, Hubscher SG, Mcmaster P et al. Invasive gastrointestinal zygomycosis in a liver transplant recipient: Case report. Transplantation 2002: 73: 145.
16. Hunstad DA, Cohen AH, St Geme JW, III. Successful eradication of mucormycosis occurring in a pulmonary allograft. J Heart Lung Transplant 1999: 18: 801.
17. Nomura J, Ruskin J, Sahebi F et al. Mucormycosis of the vulva following bone marrow transplantation. Bone Marrow Transplant 1997: 19: 859.
18. Jacobs P, Wood L, Du Toit A et al. Eradication of invasive mucormycosis - effectiveness of the echinocandin fk463. Hematology 2003: 8: 119.
19. van Burik JA, Hare RS, Solomon HF et al. Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases. Clin Infect Dis 2006: 42: e61.
20. Greenberg RN, Mullane K, van Burik JA et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006: 50: 126.